Back to mobile site
Get it on Google Play

Abbott receives FDA clearance for delivery system for premature infants

December 18, 2025 9:00 AM EST Send to a Friend
Abbott (NYSE: ABT) announced it received U.S. Food and Drug Administration clearance and CE Mark for its Amplatzer Piccolo Delivery ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login